Skip to contentB
BioCorRx Inc.
B
BICXBioCorRx Inc. Q4 2020 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$22.22K$22.22Kderived−64.4% vs Q4 2019 Net Income-$904.67K-$904.67KderivedN/M vs Q4 2019 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$1,767,232N/M Operating Cash Flowderived-$341,329N/M Margins · derivedOperating margin-7952.6%−5397.9 pt vs Q4 2019
Net margin-4071.0%−2144.6 pt vs Q4 2019
ended Dec 31, 2020 · filed Mar 31, 2021 · 90 d after period end